Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Healionics, a provider of tissue regeneration and device bio-integration solutions to healthcare manufacturers, has raised $2.6 million in a Series B financing from private investors.
Subscribe to our email newsletter
The financing includes funding from several angel networks including Bellingham Angels, Alliance of Angels, Keiretsu, Tacoma Angel Network and Zino Society.
Robert Brown, CEO of Healionics, said: “This financing reflects the great progress Healionics has made over the past year, including doubling the number of research agreements for our Star biomaterial and consistently achieving corporate milestones such as scaling up manufacturing processes, accelerating preclinical studies and advancing business development activities.
“We are pleased to receive such support in this current economic climate. These funds will enable the company to continue to make significant progress in achieving key milestones, including additional preclinical studies and development of a degradable form of Star material that will provide further evidence of the efficacy and versatility of Star biomaterial.”